Drug intelligence / Profile preview

Epaplus Sleepcare

Development stage
Unknown
Lead developer
Peroxfarma
Modality
Small Molecules
Administration
Oral
01

Overview

Epaplus Sleepcare is a dietary supplement developed by the Spanish pharmaceutical company Peroxfarma (Peróxidos Farmacéuticos) to support sleep quality and regulate the sleep-wake cycle. Its primary active ingredient is melatonin (1.98 mg), delivered in a 'Retard' extended-release tablet designed to provide sustained release over 8 hours, helping users both fall asleep and maintain sleep throughout the night. The formulation also includes tryptophan, an amino acid precursor to serotonin and melatonin, along with magnesium and vitamins B3 and B6, which act as cofactors in the endogenous synthesis of melatonin. It is indicated for individuals experiencing difficulty falling asleep, frequent nighttime awakenings, jet lag, or delayed sleep phase syndrome. The product is marketed as vegan-friendly and free from gluten, lactose, and sugar.

Brand names
Epaplus Sleepcare
02

Targets

MTNR1B (Melatonin Receptor 2)MTNR1A (MT1)

Beyond the preview

Go deeper on Epaplus Sleepcare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epaplus Sleepcare.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call